Analysis of chronic diseases associated to SARS-CoV-2 infection in children and young people in Mexico
Abstract
The emergence of COVID-19, a disease caused by SARS-CoV-2, was first reported in December 2019. It then spread in pandemic proportions, creating a human health emergency that was declared a pandemic by the World Health Organization. The airborne transmission of the SARS-CoV-2 virus, mainly through droplets of saliva, has been highly effective, depending on the viral variant. The present study provides clinical-epidemiological information on the general population without discriminating by socioeconomic and occupational factors. A total of 8507 positive cases, with 408384 official metadata, were analyzed. These cases correspond to the exponential phase of the first epidemic wave (March-June 2020) in Mexico. The cohort consisted of children and young people up to 20 years of age. The putative risk factors for SARS-CoV-2 infection due to chronic diseases were also analyzed. In this cohort, the frequency of SARS-CoV-2 infection was 3%, with a 9% rate of active infections and a mortality rate of 1%. The greatest association was between COVID-19 and metabolic diseases, with 31%. This is the first study that analyzed the health conditions associated with COVID-19 infection in children and young people in Mexico during the first SARS-CoV-2 epidemic wave, in the absence of acquired or induced immunity factors. The results, although preliminary, may contribute to the management of COVID-19 patients during the prevention and hospitalization stages. Given the sustained expansion of the epidemic and the greater availability of data, it would be useful to make an integrative analysis of the rural population, which has remained active in the labor market given that agriculture is considered an essential activity.
Keywords
Full Text:
PDFReferences
Bassareo PP, Melis MR, Marras S and Calcaterra G. 2020. Learning from the past in the COVID-19 era: rediscovery of quarantine, previous pandemics, origin of hospitals and national healthcare systems, and ethics in medicine. Postgraduate medical journal, postgradmedj-2020-138370. Advance online publication. https://doi.org/10.1136/postgradmedj-2020-138370
Basto-Abreu A, Torres-Alvare, R, Reyes-Sánchez F, González-Morales R, Canto-Osorio F, Colchero M A, Barquera S, Rivera JA and Barrientos-Gutierrez T. 2020. Predicting obesity reduction after implementing warning labels in Mexico: A modeling study. PLoS medicine 17(7): e1003221. https://doi.org/10.1371/journal.pmed.1003221
CNX. Disponible en https://cnx.org/ consultado 14 septiembre 2020
Committee on Infectious Diseases. 2020. Recommendations for Prevention and Control of Influenza in Children, 2020-2021. Pediatrics, e2020024588. Advance online publication. https://doi.org/10.1542/peds.2020-024588
El-Sayed Moustafa JS, Jackson AU, Brotman SM, Guan L, Villica?a S, Roberts AL, Zito A, Bonnycastle L, Erdos MR, Narisu N, Stringham HM, Welch R, Yan T, Lakka T, Parker S, Tuomilehto J, Collins F S, Pajukanta P, Boehnke M, Koistinen HA, … Small KS. 2020. ACE2 expression in adipose tissue is associated with COVID-19 cardio-metabolic risk factors and cell type composition. medRxiv: the preprint server for health sciences. 1-36 2020.08.11.20171108. https://doi.org/10.1101/2020.08.11.20171108
Galli L, Chiappini E and Schumacher RF. 2020. After the First Wave of COVID-19: Reflections from Italy. The Pediatric infectious disease journal 39(8): e192–e194. https://doi.org/10.1097/INF.0000000000002806
Gazzaruso C, Paolozzi E, Valenti C, Brocchetta M, Naldani D, Grignani C, Salvucci F, Marino F, Coppola A and Gallotti P. 2020. Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity. Nutrition, metabolism, and cardiovascular diseases 30(11): 1914-1919. https://doi.org/10.1016/j.numecd.2020.07.040
Guo CX, He L, Yin JY, Meng XG, Tan W, Yang GP, Bo T, Liu JP, Lin XJ and Chen X. 2020. Epidemiological and clinical features of pediatric COVID-19. BMC medicine 18(1): 250. https://doi.org/10.1186/s12916-020-01719-2
H. Congreso de Oaxaca. 2020. Disponible en https://docs64.congresooaxaca.gob.mx/documents/dictamen/1184.pdf consultado 17 de septiembre 2020
Hu T, Liu Y, Zhao M, Zhuang Q, Xu L and He Q. 2020. A comparison of COVID-19, SARS and MERS. PeerJ 8: e9725. https://doi.org/10.7717/peerj.9725
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y and Cao B. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395(10223): 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Karia R, Gupta I, Khandait H, Yadav A and Yadav A. 2020. COVID-19 and its Modes of Transmission. SN comprehensive clinical medicine 1–4. Advance online publication. https://doi.org/10.1007/s42399-020-00498-4
Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J and Wong GWK. 2020. SARS-CoV-2 infection in children. New England Journal of Medicine 382(17): 1663-1665. https://doi.org/10.1056/NEJMc2005073
OCDE. 2020. Organización para la Cooperación y el Desarrollo Económicos (OCDE). https://www.oecd.org/mexico/health-at-a-glance-mexico-ES.pdf consultado 14 de septiembre 2020
Ourworldindata. 2020 Statistics and Research Coronavirus (COVID-19) Testing. Disponible en https://ourworldindata.org/coronavirus-testing. consultado 14 de Septiembre, 2020
Pereira M, Litvinov N, Farhat S, Eisencraft AP, Gibelli M, Carvalho WB, Fernandes VR, Fink TT, Framil J, Galleti KV, Fante AL, Fonseca M, Watanabe A, Paula C, Palandri GG, Leal GN, Diniz M, Pinho J, Silva CA, Marques H, … Jorge P. 2020. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome. Clinics (Sao Paulo, Brazil) 75: e2209. https://doi.org/10.6061/clinics/2020/e2209
Ruan P S, Xu HQ, Wu JH, Song QF and Qiu HY. 2020. COVID-19 in Children: Clinical Characteristics and Follow-Up Study. SN comprehensive clinical medicine 1–4. Advance online publication. https://doi.org/10.1007/s42399-020-00502-x
DOI: http://dx.doi.org/10.18781/R.MEX.FIT.2021-26
Refbacks
- There are currently no refbacks.